Old Web
English
Sign In
Acemap
>
authorDetail
>
J.D. Lawson
J.D. Lawson
Takeda Pharmaceutical Company
Receptor tyrosine kinase
Biology
Biochemistry
Tyrosine kinase
Immunology
3
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridine as Anaplastic Lymphoma Kinase (ALK) Inhibitors
2019
Journal of Medicinal Chemistry
Makoto Fushimi
I. Fujimori
Takeshi Wakabayashi
Tomoaki Hasui
Youichi Kawakita
Keisuke Imamura
Takeshi Kato
Morio Murakami
Tsuyoshi Ishii
Y. Kikko
M. Kasahara
A. Nakatani
Y. Hiura
Masaomi Miyamoto
Kumar Singh Saikatendu
Hua Zou
S.W. Lane
J.D. Lawson
Hiroshi Imoto
Show All
Source
Cite
Save
Citations (7)
MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody.
2017
Molecular Cancer Therapeutics
Pamela Farrell
Jennifer Matuszkiewicz
Deepika Balakrishna
S. Pandya
Hixon
Ruhi Kamran
S. Chu
J.D. Lawson
Kengo Okada
Akira Hori
Akio Mizutani
Hidehisa Iwata
R. de Jong
B. Hibner
Patrick Vincent
Show All
Source
Cite
Save
Citations (4)
A Back-to-Front Fragment-Based Drug Design Search Strategy Targeting the DFG-Out Pocket of Protein Tyrosine Kinases.
2012
ACS Medicinal Chemistry Letters
Hidehisa Iwata
Hideyuki Oki
Kengo Okada
Terufumi Takagi
Michiko Tawada
Y. Miyazaki
Shinichi Imamura
Akira Hori
J.D. Lawson
Mark S. Hixon
Hiroyuki Kimura
Hiroshi Miki
Show All
Source
Cite
Save
Citations (18)
1